Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

12345678910

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

2nd Jul 2026 17:04

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike across the pond. Read More

UK dividends calendar - next 7 days

2nd Jul 2026 14:14

Read More

LONDON MARKET CLOSE: Mid-caps shine but AB Foods holds back FTSE 100

1st Jul 2026 17:00

(Alliance News) - Stocks ended mixed in London on Wednesday with US rate hike worries and a decline in Primark owner Associated British Foods hitting blue-chips, while mid-caps prospered. Read More

LONDON BROKER RATINGS: UBS, RBC and Citi cut easyJet; UBS lowers Mondi

30th Jun 2026 09:21

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: RBC ups Central Asia Metals to 'sector perform'

29th Jun 2026 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

29th Jun 2026 07:57

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts. Read More

GSK launches tender offer for USD10.6 billion purchase of Nuvalent

24th Jun 2026 15:45

(Alliance News) - GSK PLC on Wednesday said it has launched the tender offer for its previously announced acquisition of US-based cancer drug developer Nuvalent Inc for USD10.6 billion. Read More

IN BRIEF: GSK executives, including non-exec chair, buy shares

23rd Jun 2026 20:20

GSK PLC - London-based pharmaceuticals firm - Non-Executive Chair Jonathan Symonds buys 1,550 shares at GBP19.35 for total GBP29,992.50 last Friday. Director Vishal Sikka buys 1,266 ADS for USD50.69 each, for total USD64,175 on Monday, and Director Charles Bancroft buys 1,855 ADS for USD50.69 each, total USD94,031, also on Monday Read More

GSK says US FDA approves urinary tract infection treatment Utebzi

17th Jun 2026 21:36

(Alliance News) - GSK PLC and Spero Therapeutics Inc on Wednesday said that the US Food & Drug Administration has approved Utebzi, an oral antibiotic for the treatment of complicated urinary tract infections. Read More

GSK drug momelotinib gains regulatory nods as VEXAS treatment

12th Jun 2026 10:05

(Alliance News) - GSK PLC on Friday announced that momelotinib has received orphan drug designation from the US Food & Drug Administration, and the European Medicines Agency, to treat VEXAS syndrome. Read More

LONDON BRIEFING: UK economy contracts in April; Flutter to leave LSE

12th Jun 2026 07:58

(Alliance News) - The UK economy contracts 0.1% in April, Flutter Entertainment says it will delist from the London Stock Exchange in August, while Alternative Income REIT's largest shareholder makes a takeover bid. Read More

LONDON MARKET MIDDAY: FTSE 100 lags Europe as oil majors, GSK weigh

9th Jun 2026 12:10

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, as the FTSE 100 lagged European peers despite renewed optimism for a peace deal in the Middle East, as oil majors and GSK weighed on the blue-chip index. Read More

WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps

9th Jun 2026 10:34

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON MARKET OPEN: FTSE 100 down as GSK buys US drugmaker Nuvalent

9th Jun 2026 09:09

(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 fell after GSK agreed to buy US-based cancer drug developer Nuvalent for USD10.6 billion. Read More

UPDATE: GSK buys cancer drug developer Nuvalent for USD10.6 billion

9th Jun 2026 09:00

(Alliance News) - GSK PLC on Tuesday said it has agreed to US-based cancer drug developer Nuvalent Inc for USD10.6 billion. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

LONDON MARKET EARLY CALL: FTSE 100 to rise as Israel, Iran end attacks

9th Jun 2026 06:51

(Alliance News) - Stocks in London are set to open slightly higher on Tuesday, after Iran and Israel said they would end recent hostilities that had threatened peace talks. Read More

GSK hails "major step forward" after "positive" hepatitis drug results

28th May 2026 10:57

(Alliance News) - GSK PLC on Thursday reported "positive" phase 3 trial data for its hepatitis B treatment, Bepirovirsen, which it said could "redefine" treatment for the disease. Read More

GSK's RSV vaccine Arexvy approved in Japan for some adults under 50

18th May 2026 08:36

(Alliance News) - GSK PLC on Monday announced that Japan's Ministry of Health, Labour & Welfare expanded the eligible population for its respiratory syncytial virus vaccine Arexvy. Read More

WINNERS & LOSERS: Miners slide; Centrica to pay GBP20 million to Ofgem

15th May 2026 10:30

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

12345678910
FTSE 100 Latest
Value10,679.03
Change26.16